These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6752643)

  • 41. COX-2 inhibitors selectively block prostacyclin synthesis in endotoxin-exposed vascular smooth muscle cells.
    Schildknecht S; Bachschmid M; Baumann A; Ullrich V
    FASEB J; 2004 Apr; 18(6):757-9. PubMed ID: 14977876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Significance of the PGI2 producing enzyme system in the pathogenesis of pregnancy-induced hypertension].
    Seki H; Mitsuhashi N; Mizuno M; Satoh K
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1189-94. PubMed ID: 2120373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulation of prostaglandin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells.
    Chang WC; Nakao J; Orimo H; Murota SI
    Biochim Biophys Acta; 1980 Dec; 620(3):472-82. PubMed ID: 6786344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Some properties of prostacyclin synthase from pig aorta.
    Wlodawer P; Hammarström S
    FEBS Lett; 1979 Jan; 97(1):32-6. PubMed ID: 367815
    [No Abstract]   [Full Text] [Related]  

  • 45. Induction of prostacyclin/PGI2 synthase expression after cerebral ischemia-reperfusion.
    Fang YC; Wu JS; Chen JJ; Cheung WM; Tseng PH; Tam KB; Shyue SK; Chen JJ; Lin TN
    J Cereb Blood Flow Metab; 2006 Apr; 26(4):491-501. PubMed ID: 16094316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibodies that inhibit enzyme activity of 3-methylcholanthrene-induced cytochrome P-450.
    Park SS; Fujino T; West D; Guengerich FP; Gelboin HV
    Cancer Res; 1982 May; 42(5):1798-808. PubMed ID: 6175397
    [No Abstract]   [Full Text] [Related]  

  • 47. Selective thromboxane synthetase inhibitors. 2. 3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogues.
    Cross PE; Dickinson RP; Parry MJ; Randall MJ
    J Med Chem; 1986 Mar; 29(3):342-6. PubMed ID: 3081722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ovarian stimulation with human chorionic gonadotropin and equine chorionic gonadotropin affects prostacyclin and its receptor expression in the porcine oviduct.
    Małysz-Cymborska I; Andronowska A
    Domest Anim Endocrinol; 2015 Oct; 53():17-25. PubMed ID: 26069941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparin and acidic fibroblast growth factor interact to decrease prostacyclin synthesis in human endothelial cells by affecting both prostaglandin H synthase and prostacyclin synthase.
    Weksler BB
    J Cell Physiol; 1990 Mar; 142(3):514-22. PubMed ID: 2107185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of complement activation on the biosynthesis of prostacyclin (PGI2) by rabbit peritoneum in vitro.
    Rampart M; Bult H; Herman AG
    Arch Int Pharmacodyn Ther; 1981 Oct; 253(2):327-9. PubMed ID: 7034666
    [No Abstract]   [Full Text] [Related]  

  • 51. Synthesis of prostacyclin and thromboxane A2 by rat gastric mucosa. Comparison of 1,6-dimethyl-4-oxo-1,6,7,8,9,9a-hexahydro-4H-pyrido (1,1-a)-pyrimidine-3-carboxamide and cimetidine.
    Rózsa I; Kapui Z; Szécsi T; Hermecz I; Blaskó G
    Arzneimittelforschung; 1989 Jun; 39(6):686-9. PubMed ID: 2673252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of prostacyclin synthesis in cultured bovine aortic endothelial cells by vitamin K1.
    Nolan RD; Eling TE
    Biochem Pharmacol; 1986 Dec; 35(23):4273-81. PubMed ID: 3098248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of human serum complement stimulates prostacyclin production by isolated rabbit peritoneum.
    Rampart M; Bult H; Herman AG
    Agents Actions Suppl; 1982; 11():225-31. PubMed ID: 6758552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dipyridamole: a potent stimulator of prostacyclin (PGI2) biosynthesis.
    Blass KE; Block HU; Förster W; Pönicke K
    Br J Pharmacol; 1980 Jan; 68(1):71-3. PubMed ID: 6766769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of vascular epoprostenol (prostacyclin, PGI2) production in vitro by plasma from healthy subjects and patients with severe renal impairment.
    Ritter JM; Orchard MA; Lewis PJ
    Br J Clin Pharmacol; 1982 Sep; 14(3):379-83. PubMed ID: 6751363
    [No Abstract]   [Full Text] [Related]  

  • 56. [Prostacyclin; clinical aspects].
    Sitsen JM; Nijkamp FP
    Ned Tijdschr Geneeskd; 1983 Jan; 127(5):199-206. PubMed ID: 6338406
    [No Abstract]   [Full Text] [Related]  

  • 57. Low prostacyclin synthetase activity of fetal rat aorta. Progressive increase after birth.
    Deckmyn H; Font L; Van Hemelen C; Carreras LO; Defreyn G; Vermylen J
    Life Sci; 1983 Oct; 33(15):1491-7. PubMed ID: 6413801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C-reactive protein decreases prostacyclin release from human aortic endothelial cells.
    Venugopal SK; Devaraj S; Jialal I
    Circulation; 2003 Oct; 108(14):1676-8. PubMed ID: 14504187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben.
    Olson RW; Cohen DS; Ku EC; Kimble EF; Renfroe HB; Smith EF
    Eur J Pharmacol; 1987 Jan; 133(3):265-73. PubMed ID: 3104066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes.
    Salmon JA; Smith DR; Flower RJ; Moncada S; Vane JR
    Biochim Biophys Acta; 1978 Mar; 523(1):250-62. PubMed ID: 415760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.